Renal Cell Carcinoma Global Clinical Trials Review, H1, 2012

Renal Cell Carcinoma Global Clinical Trials Review, H1, 2012

Summary

GlobalData's clinical trial report, “Renal Cell Carcinoma Global Clinical Trials Review, H1, 2012" provides data on the Renal Cell Carcinoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Renal Cell Carcinoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Renal Cell Carcinoma. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

• Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
• Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
• Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

• Understand the dynamics of a particular indication in a condensed manner
• Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
• Obtain discontinued trial listing for trials across the globe
• Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Contents

Introduction
Renal Cell Carcinoma
Report Guidance
Clinical Trials by Region
Clinical Trials by Country
Top Five Countries Contributing to Clinical Trials in Asia-Pacific
Top Five Countries Contributing to Clinical Trials in Europe
Top Countries Contributing to Clinical Trials in North America
Top Five Countries Contributing to Clinical Trials in Middle East and Africa
Top Five Countries Contributing to Clinical Trials in Central and South America
Clinical Trials by BRIC Nations
Clinical Trials by G7 Nations
Clinical Trials in G7 Nations by Trial Status
Clinical Trials by E7 Nations
Clinical Trials in E7 Nations by Trial Status
Clinical Trials by Phase
In Progress Trials by Phase
Clinical Trials by Trial Status
Unaccomplished Trials of Renal Cell Carcinoma
Subjects Recruited Over a Period of Time
Prominent Sponsors
Top Companies Participating in Renal Cell Carcinoma Therapeutics Clinical Trials
Prominent Drug Comparison
Clinical Trial Profiles
Clinical Trial Overview of Top Companies
Pfizer Inc.
Clinical Trial Overview of Pfizer Inc.
GlaxoSmithKline plc
Clinical Trial Overview of GlaxoSmithKline plc
Novartis AG
Clinical Trial Overview of Novartis AG
Bayer AG
Clinical Trial Overview of Bayer AG
Amgen Inc.
Clinical Trial Overview of Amgen Inc.
Bristol-Myers Squibb Company
Clinical Trial Overview of Bristol-Myers Squibb Company
F. Hoffmann-La Roche Ltd.
Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
AVEO Pharmaceuticals, Inc.
Clinical Trial Overview of AVEO Pharmaceuticals, Inc.
Agenus, Inc.
Clinical Trial Overview of Agenus, Inc.
Eli Lilly and Company
Clinical Trial Overview of Eli Lilly and Company
Argos Therapeutics, Inc.
Clinical Trial Overview of Argos Therapeutics, Inc.
Celgene Corporation
Clinical Trial Overview of Celgene Corporation
AstraZeneca PLC
Clinical Trial Overview of AstraZeneca PLC
Bayer HealthCare AG
Clinical Trial Overview of Bayer HealthCare AG
Abbott Laboratories
Clinical Trial Overview of Abbott Laboratories
Genzyme Corporation
Clinical Trial Overview of Genzyme Corporation
Genentech, Inc.
Clinical Trial Overview of Genentech, Inc.
Astellas Pharma Inc.
Clinical Trial Overview of Astellas Pharma Inc.
Active Biotech AB
Clinical Trial Overview of Active Biotech AB
Clinical Trial Overview of Top Universities / Institutes / Hospitals
The University of Texas M. D. Anderson Cancer Center
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center
Beth Israel Deaconess Medical Center
Clinical Trial Overview of Beth Israel Deaconess Medical Center
Sarah Cannon Research Institute
Clinical Trial Overview of Sarah Cannon Research Institute
University Health Network
Clinical Trial Overview of University Health Network
Roswell Park Cancer Institute
Clinical Trial Overview of Roswell Park Cancer Institute
Case Comprehensive Cancer Center
Clinical Trial Overview of Case Comprehensive Cancer Center
UCLA's Jonsson Comprehensive Cancer Center
Clinical Trial Overview of UCLA's Jonsson Comprehensive Cancer Center
Radboud University
Clinical Trial Overview of Radboud University
Seoul National University Hospital
Clinical Trial Overview of Seoul National University Hospital
Cambridge University Hospitals NHS Foundation Trust
Clinical Trial Overview of Cambridge University Hospitals NHS Foundation Trust
The Methodist Hospital System
Clinical Trial Overview of The Methodist Hospital System
Duke University
Clinical Trial Overview of Duke University
Assistance Publique - Hopitaux de Paris
Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
Stanford University
Clinical Trial Overview of Stanford University
University of Colorado
Clinical Trial Overview of University of Colorado
Kobe University
Clinical Trial Overview of Kobe University
Kidney Cancer Research Bureau
Clinical Trial Overview of Kidney Cancer Research Bureau
St. Joseph's Healthcare Hamilton
Clinical Trial Overview of St. Joseph's Healthcare Hamilton
Abramson Cancer Center
Clinical Trial Overview of Abramson Cancer Center
Five Key Clinical Profiles
Appendix
Abbreviations
Definitions
Research Methodology
Secondary Research
About GlobalData
Contact Us
Disclaimer
Source

LIST OF TABLES

Renal Cell Carcinoma Therapeutics Market, Global, Clinical Trials by Zone, 2012*
Renal Cell Carcinoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Renal Cell Carcinoma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials, North America, Top Countries, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials, BRIC Countries, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials, G7 Countries, 2012*
Renal Cell Carcinoma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials, E7 Countries, 2012*
Renal Cell Carcinoma Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Renal Cell Carcinoma Therapeutics Market, Global, Clinical Trials by Phase, 2012*
Renal Cell Carcinoma Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012*
Renal Cell Carcinoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Renal Cell Carcinoma Therapeutics Market, Global, Suspended Clinical Trials, 2012*
Renal Cell Carcinoma Therapeutics Market, Global, Withdrawn Clinical Trials, 2012*
Renal Cell Carcinoma Therapeutics Market, Global, Terminated Clinical Trials, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Renal Cell Carcinoma Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Bristol-Myers Squibb Company, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by AVEO Pharmaceuticals, Inc., 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Agenus, Inc., 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Argos Therapeutics, Inc., 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer HealthCare AG, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Genzyme Corporation, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Genentech, Inc., 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Active Biotech AB, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Beth Israel Deaconess Medical Center, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Sarah Cannon Research Institute, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Roswell Park Cancer Institute, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Case Comprehensive Cancer Center, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by UCLA's Jonsson Comprehensive Cancer Center, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Cambridge University Hospitals NHS Foundation Trust, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by The Methodist Hospital System, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Kobe University, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Kidney Cancer Research Bureau, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Joseph's Healthcare Hamilton, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials Market, Global, Clinical Trials by Abramson Cancer Center, 2012*

LIST OF FIGURES

Renal Cell Carcinoma Therapeutics Market, Global, Clinical Trials by Zone (%), 2012*
Renal Cell Carcinoma Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
Renal Cell Carcinoma Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials, North America, Top Countries (%), 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials, BRIC Countries (%), 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials, G7 Countries (%), 2012*
Renal Cell Carcinoma Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials, E7 Countries (%), 2012*
Renal Cell Carcinoma Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
Renal Cell Carcinoma Therapeutics Market, Global, Clinical Trials by Phase (%), 2012*
Renal Cell Carcinoma Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012*
Renal Cell Carcinoma Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
Renal Cell Carcinoma Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
Renal Cell Carcinoma Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
GlobalData Methodology Skip to top